GLP-2: The Other Gut Hormone You Should Know About

GLP-2: The Other Gut Hormone You Should Know About

By Dr. Onikepe Adegbola, MD PhD

Everyone's talking about GLP-1. It's the basis for semaglutide, tirzepatide, and the wave of medications reshaping obesity and diabetes treatment. But GLP-1 has a sibling that gets almost no public attention: GLP-2.

GLP-2 (also searched as GLP 2) — glucagon-like peptide-2 — is produced by the same intestinal L-cells, at the same time, from the same prohormone precursor as GLP-1. Yet it does something fundamentally different. While GLP-1 suppresses appetite and regulates blood sugar, GLP-2 repairs and maintains the lining of your gut.

For patients on GLP-1 medications dealing with persistent GI side effects, understanding GLP 2 (GLP-2) adds context to what's happening in your digestive system — and why gut health support matters during treatment.

What GLP-2 Does: The Gut's Repair Hormone

If GLP-1 is the metabolic regulator, GLP-2 is the construction foreman. Its primary role is maintaining and repairing the intestinal epithelium — the single-cell-thick lining that separates your gut contents from your bloodstream.

This lining is one of the most actively dividing tissues in your body. Intestinal epithelial cells turn over every 3–5 days. The constant renewal requires a steady supply of growth signals, and GLP-2 is one of the most important.

Specifically, GLP-2:

• Stimulates intestinal crypt cell proliferation — the stem cells at the base of intestinal villi that generate new epithelial cells
• Inhibits apoptosis — reduces programmed cell death in intestinal epithelial cells, allowing the lining to maintain its integrity
• Increases intestinal blood flow — promotes the vascular supply that supports nutrient absorption and tissue repair
• Enhances nutrient absorption — increases the absorptive surface area and upregulates nutrient transporters in the intestinal lining
• Strengthens the intestinal barrier — supports tight junction proteins that prevent unwanted substances from crossing from the gut lumen into the bloodstream

In simple terms: GLP-2 helps your gut grow, repair itself, absorb nutrients better, and keep its barrier function intact. These aren't subtle effects. In animal models, GLP-2 administration produces visible increases in intestinal villus height and crypt depth within days.

GLP-2 vs. GLP-1: Same Origin, Different Jobs

Both GLP-1 and GLP-2 are produced from the same precursor molecule — proglucagon — in intestinal L-cells. When you eat, both hormones are released simultaneously into circulation. But they act on completely different receptor systems with distinct downstream effects.

Here's how they compare:

• GLP-1: Suppresses appetite, slows gastric emptying, stimulates insulin secretion, reduces glucagon. Primary target: metabolic regulation and blood sugar control.
• GLP-2: Promotes intestinal growth and repair, increases nutrient absorption, enhances gut barrier function, increases intestinal blood flow. Primary target: gut health and intestinal integrity.

Both hormones have short half-lives. Native GLP-2 lasts about 7 minutes before DPP-4 degrades it — longer than GLP-1's 2-minute half-life, but still brief. The pharmaceutical GLP-2 analog (teduglutide) has been engineered to resist DPP-4 breakdown, extending its half-life to approximately 2 hours.

One point that often surprises people: GLP-2 has minimal effects on appetite or blood sugar. Despite sharing a precursor and co-release pattern with GLP-1, GLP-2 doesn't appear to play a meaningful role in metabolic regulation. It's highly specialized for gut tissue maintenance.

Teduglutide: The Approved GLP-2 Medication

Teduglutide (brand name Gattex in the US, Revestive in Europe) is the only approved GLP-2 analog. It received FDA approval in 2012 for the treatment of short bowel syndrome (SBS) in adults requiring parenteral support (IV nutrition).

Short bowel syndrome occurs when a large portion of the small intestine has been surgically removed — often due to Crohn's disease, mesenteric ischemia, radiation damage, or trauma. Patients with insufficient remaining intestine can't absorb adequate nutrition from food and depend on intravenous nutrition to survive.

Teduglutide works by doing what natural GLP-2 does — but at pharmacological levels and with sustained activity. It stimulates the remaining intestinal tissue to grow and adapt: villi become taller, absorption capacity increases, and patients can often reduce or eliminate their dependence on IV nutrition.

Clinical trial results were meaningful. In the pivotal STEPS trial, 63% of patients treated with teduglutide achieved clinically significant reductions in parenteral nutrition volume at 24 weeks, compared to 30% with placebo. Some patients were able to stop IV nutrition entirely — a dramatic improvement in quality of life for a population that previously had no pharmacological options.

Limitations and Costs

Teduglutide is expensive — list prices exceed $30,000 per month — and requires daily subcutaneous injections. It also carries monitoring requirements: colonoscopy before starting and every 1–2 years during treatment, because stimulating intestinal cell growth raises theoretical concerns about polyp formation.

The high cost and narrow indication mean most physicians and patients encounter teduglutide rarely. But the science behind it illuminates the broader relevance of GLP-2 biology.

Why GLP-2 Matters for GLP-1 Medication Users

Here's where this connects to the much larger population of patients on GLP-1 medications for weight loss and diabetes.

GLP-1 receptor agonists slow gastric emptying, change the digestive environment, and alter the food patterns that drive gut hormone secretion. The GI side effects that patients experience — nausea, constipation, diarrhea, bloating — reflect changes in gut motility and digestive function.

GLP-2's role in maintaining the intestinal lining and supporting nutrient absorption becomes particularly relevant when:

• Reduced food intake means less stimulation of L-cells, potentially reducing natural GLP-2 (and GLP-1) secretion over time
• Altered gut transit changes how long nutrients are in contact with the absorptive surface of the intestine
• Microbiome shifts during GLP-1 treatment may affect the SCFA production that supports both GLP-1 and GLP-2 secretion
• Nutrient absorption may be affected when the foods you do eat pass through a digestive system operating under altered conditions

Supporting gut health during GLP-1 treatment isn't just about managing side effects — it's about maintaining the intestinal infrastructure that GLP-2 normally supports. This includes feeding beneficial gut bacteria, maintaining adequate fiber intake, and using targeted digestive support.

A synbiotic supplement like the GLP-1 Digestive Support Synbiotic supports the bacterial populations that produce SCFAs — the same short-chain fatty acids that stimulate L-cells to release both GLP-1 and GLP-2. The GLP-1 Digestive Enzyme Companion helps ensure you're actually absorbing the nutrients from the food you do eat.

Emerging Research: Where GLP-2 Science Is Heading

Beyond short bowel syndrome, researchers are investigating GLP-2's potential in several areas:

Inflammatory Bowel Disease

GLP-2's ability to promote mucosal healing and strengthen the intestinal barrier makes it a natural candidate for IBD treatment. Preclinical data shows GLP-2 reduces intestinal inflammation and promotes tissue repair in colitis models. Clinical trials in Crohn's disease and ulcerative colitis are in early stages.

Bone Health

An unexpected finding: GLP-2 appears to reduce bone resorption. Administering GLP-2 at bedtime — when bone resorption normally accelerates — reduced markers of bone breakdown in postmenopausal women. This has implications for osteoporosis management and for patients on GLP-1 medications who may experience bone density changes during rapid weight loss.

Intestinal Barrier ("Leaky Gut")

The concept of increased intestinal permeability — often called "leaky gut" — has moved from fringe theory to mainstream research. GLP-2's role in supporting tight junction integrity positions it as a potential therapeutic target for conditions associated with barrier dysfunction, including celiac disease, food allergies, and metabolic endotoxemia.

Post-Surgical Recovery

GLP-2's ability to accelerate intestinal adaptation makes it relevant for patients recovering from intestinal surgery — not just those with short bowel syndrome, but anyone who's lost intestinal tissue. Research into shorter courses of GLP-2 analogs for post-operative recovery is ongoing.

Frequently Asked Questions

Is GLP-2 the same as GLP-1?

No. GLP-1 and GLP-2 are distinct hormones produced from the same precursor molecule in the same intestinal cells. GLP-1 primarily regulates appetite, blood sugar, and metabolism. GLP-2 primarily maintains and repairs the intestinal lining. They work on different receptors and have different biological effects, though they are released together in response to food.

Can I take GLP-2 for weight loss?

GLP-2 has no meaningful effects on appetite or weight. It's a gut-specific growth factor, not a metabolic regulator. The approved GLP-2 analog (teduglutide) is only used for short bowel syndrome. GLP-1 — not GLP-2 — is the hormone behind weight loss medications like semaglutide and tirzepatide.

How do I increase my GLP-2 levels naturally?

Since GLP-2 is co-released with GLP-1 from intestinal L-cells, the same dietary strategies that boost GLP-1 also increase GLP-2: high-protein meals, dietary fiber (especially fermentable fiber that produces short-chain fatty acids), healthy fats, and a diverse gut microbiome. Regular meals that stimulate L-cells maintain healthy GLP-2 secretion.

Does GLP-2 help with gut problems from Ozempic or Wegovy?

There's no approved use of GLP-2 for managing GLP-1 medication side effects. However, supporting your body's natural GLP-2 production through diet and gut health may help maintain intestinal barrier function during GLP-1 treatment. Feeding beneficial gut bacteria with appropriate fiber and probiotics supports the SCFA production that stimulates both GLP-1 and GLP-2 release.

What is the medication Gattex used for?

Gattex (teduglutide) is a GLP-2 analog approved for adults and children with short bowel syndrome who require parenteral nutrition (IV feeding). It stimulates intestinal tissue growth and adaptation, helping patients absorb more nutrition from food and reducing their dependence on IV nutrition. It's administered as a daily subcutaneous injection.